Evaluation on the effect of TCM Syndrome Differentiation and Treatment based on community/isolated population in preventing novel coronavirus pneumonia (COVID-19)
Phase 1
Recruiting
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2100004748
- Lead Sponsor
- The Affiliated Hospital to Changchun University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Target population over 18 years old;
2. On the basis of routine protection, agree to conduct syndrome differentiation and treatment, and be able to follow the plan to take drugs;
3. Volunteer to participate in this clinical observation.
Exclusion Criteria
1. Those who are allergic to the known ingredients of the drug;
2. Those who cannot take preventive preparations;
3. People with mental disorders or combined with major diseases such as cardiovascular, respiratory system, liver, and kidney;
4. People who have reading ability barriers and cannot cooperate with data collection;
5. Others who are not suitable to participate in this study.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Confirmed 2019-ncov pneumonia;
- Secondary Outcome Measures
Name Time Method TCM symptoms;